The second amendment to the MDR/IVDR standardisation request M/575 has been adopted on 27 May 2024 as “COMMISSION IMPLEMENTING DECISION amending Implementing Decision C(2021) 2406 on a standardisation request to the European Committee for Standardization and the European Committee for Electrotechnical Standardization as regards medical devices in support of Regulation (EU) 2017/745 of the European Parliament and of the Council and in vitro diagnostic medical devices in support of Regulation (EU) 2017/746 of the European Parliament and of the Council, as regards the scope and validity of the request and the deadlines for the joint final report and for the adoption of certain harmonised standards, certain general requirements and the requirements for certain specific standards (C(2024)3371)”.
News & Trends
Procurar
Recentes
- Relatório Anual da Gestão da Disponibilidade de Medicamentos de 2024
- Bioanalytical Method Validation for Biomarkers
- MEDTECH AND DIGITAL HEALTH: A COMPREHENSIVE GUIDE TO MARKET ACCESS IN GERMANY.
- Questions & Answers for applicants, marketing authorisation holders of medicinal products and notified bodies with respect to the implementation of the Regulations on medical devices and in vitro diagnostic medical devices (Regulations (EU) 2017/745 and (EU) 2017/746)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices
- MDCG 2019-6 Rev5 Questions and answers: Requirements relating to notified bodies Revision 5 – February 2025
- Formação, Alteração e Revisão Anual de PREÇOS de MEDICAMENTOS: “Formação muito enriquecedora sobre o tema”
- EU Cosmetics Deadlines – New Rules Effective 01 February 2025